BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld
BioWorld
May 30, 2008
View Archived Issues
Kosan's Cancer Pipeline Attracts $5.50 Per Share BMS Buyout Bid
Kosan Biosciences Inc. is being snatched up by Bristol-Myers Squibb Co. for $5.50 per share, becoming the latest acquisition as big pharma struggles to fill dwindling pipelines. (BioWorld Today)
Read More
FDA Documents Critical of Ligand's Promacta
Read More
Onconase Misses Endpoint, Rolling NDA to Proceed
Read More
NewCo News: EnzymeRx Makes a $14 Million Start with Uricase Acquisition
Read More
Drug Labeling Rule Proposed for Those Pregnant, Breastfeeding
Read More
Favrille Laying Off 132 After Specifid Fails Pivotal Trial
Read More
Other News To Note
Read More
Clinic Roundup
Read More
